Millions more Americans could access obesity drugs after Trump’s deals with Eli Lilly, Novo Nordisk
US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC on Nov. ...
Tag: Pharmaceuticals
Where the blockbuster weight loss drug market stands today — and what’s coming next
A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...
CVS beats estimates, hikes guidance as insurance business improves
Signage for a CVS pharmacy in Takoma Park, Maryland, US, on Wednesday, July 9, 2025. Al Drago | Bloomberg | ...
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesPfizer on Monday said it would buy weight loss drugmaker Metsera ...
Eli Lilly to build $5 billion Virginia facility to boost production of targeted cancer drugs, other treatments
Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | ReutersEli Lilly on ...
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021.Dado ...
CDC asks all staff to return to office Sept. 15, five weeks after shooting at headquarters
A sign for the CDC sits outside of their facility at the Centers for Disease Control and Prevention Roybal campus ...
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott ...
FDA approves first-ever glucose monitoring system for weight loss from Signos
Woman with Signos wearable and appSource: SignosThe Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically ...
Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
